Good morning guys..:-) Just a quick question regarding possible treatment of HCV/HIV (separate and co-infected) with our BIT225. So far our trials are based in combination with interferon and ribavirin (IFN/RBV). As there are other newer drugs on the market is it possible that after successful results in this combination BIT225 may be combined with them also? And will it be possible just to include BIT225 with other regime of treatments after only short small trials or do you think the whole new set of data will be required before those new combinations can happen? I believe we will be a sounding success if we are just added to IFN/RBV treatment improving it significantly but there may be a scope for us to be part of ALL or majority of other treatments available out there. Do you see it as a possibility? Thank you in advance for your comments on the issue..:-)
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
0.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $2.654M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 49 | 31975625 | 0.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.3¢ | 14366964 | 19 |
View Market Depth
| Last trade - 16.30pm 18/07/2025 (20 minute delay) ? |
| BIT (ASX) Chart |
Day chart unavailable